EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders

Xinxin Gao iD, Harini Kaluarachchi, Yingnan Zhang, Sunhee Hwang, Rami N Hannoush iD

PLOS ONE · 28.03.2024 · 19 (3) · e0299804

DOI: 10.1371/journal.pone.0299804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 28.03.2024. Verfasst von Xinxin Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Early Discovery Biochemistry, Genentech, South San Francisco, California, United States of America. Hauptthemen laut MEDLINE: Peptide Library, Bacteriophages. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disulfide constrained peptides (DCPs) show great potential as templates for drug discovery. They are characterized by conserved cysteine residues that form intramolecular disulfide bonds. Taking advantage of phage display technology, we designed and generated twenty-six DCP phage libraries with enriched molecular diversity to enable the discovery of ligands against disease-causing proteins of interest. The libraries were designed based on five DCP scaffolds, namely Momordica charantia 1 (Mch1), gurmarin, Asteropsin-A, antimicrobial peptide-1 (AMP-1), and potato carboxypeptidase inhibitor (CPI). We also report optimized workflows for screening and producing synthetic and recombinant DCPs. Examples of novel DCP binders identified against various protein targets are presented, including human IgG Fc, serum albumin, vascular endothelial growth factor-A (VEGF-A) and platelet-derived growth factor (PDGF). We identified DCPs against human IgG Fc and serum albumin with sub-micromolar affinity from primary panning campaigns, providing alternative tools for potential half-life extension of peptides and small protein therapeutics. Overall, the molecular diversity of the DCP scaffolds included in the designed libraries, coupled with their distinct biochemical and biophysical properties, enables efficient and robust identification of de novo binders to drug targets of therapeutic relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptide LibraryBacteriophagesHumansVascular Endothelial Growth Factor ADisulfidesPeptidesImmunoglobulin G

Substanzen

Peptide LibraryVascular Endothelial Growth Factor ADisulfidesPeptidesImmunoglobulin G

Autor:innen und Institutionen

  • Department of Early Discovery Biochemistry, Genentech, South San Francisco, California, United States of America.
  • Department of Peptide Therapeutics, Genentech, South San Francisco, California, United States of America.
  • Department of Biological Chemistry, Genentech, South San Francisco, California, United States of America.

ORCID-Profile: Xinxin Gao, Rami N Hannoush

Zitieren

APA

Gao, X., Kaluarachchi, H., Zhang, Y., Hwang, S., & Hannoush, R. N. (2024). A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders. PLOS ONE, 19(3), e0299804. https://doi.org/10.1371/journal.pone.0299804

Vancouver

Gao X, Kaluarachchi H, Zhang Y, Hwang S, Hannoush RN. A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders. PLOS ONE. 2024;19(3):e0299804. doi:10.1371/journal.pone.0299804

BibTeX
@article{Gao2024,
  author = {Gao, Xinxin and Kaluarachchi, Harini and Zhang, Yingnan and Hwang, Sunhee and Hannoush, Rami N},
  title = {A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {3},
  pages = {e0299804},
  doi = {10.1371/journal.pone.0299804}
}
Kostenlos starten →